Zoloft While Breastfeeding: Is Sertraline Safe for Your Baby?
Author:
Blossom Editorial
Zoloft (sertraline) is one of the most studied antidepressants during breastfeeding, and many experts consider it a preferred choice for nursing mothers who need treatment for depression or anxiety. Only a very small amount passes into breast milk, and the medication itself is often undetectable in breastfed infants’ blood.
Deciding whether to take medication while breastfeeding can bring up a lot of worry, especially when you're already exhausted and caring for a newborn. Understanding what research shows about sertraline and breast milk can help you have a more confident conversation with your provider about what's right for you and your baby.
Key Takeaways
Postpartum depression is common and very treatable: In a CDC analysis of U.S. data from 2018, about 13% of respondents reported postpartum depressive symptoms after childbirth. Although the figure doesn’t represent clinically confirmed postpartum diagnoses, the fact remains that untreated depression can affect both parent and baby.
Very little sertraline reaches your baby: Breastfed babies typically receive around 0.2% to 2.4% of the parent's weight-adjusted dose. In a large analysis, about 87% of infant blood samples had no detectable sertraline.
Talk with your provider and your baby's pediatrician: Major guidelines suggest you don't have to choose between breastfeeding and treatment, but your care team can help weigh your history, your baby's health, and any concerns about milk supply.
What is Zoloft?
Zoloft is the brand name for sertraline, a selective serotonin reuptake inhibitor (SSRI) and one of the most commonly prescribed antidepressants in the U.S. SSRIs increase the availability of serotonin, a brain chemical involved in mood, sleep, anxiety, and stress.
Zoloft is FDA-approved for several conditions in adults, including major depression, panic disorder, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), social anxiety disorder, and premenstrual dysphoric disorder (PMDD). It's also widely used off-label for depression and anxiety during pregnancy and after birth.
Is Zoloft Safe While Breastfeeding? What the Research Shows
Zoloft has been studied in breastfeeding mothers and infants more than most antidepressants. The research generally finds very low infant exposure, though as with any medication, no one can promise zero risk.
How Much Sertraline Gets Into Breast Milk
Only a tiny fraction of sertraline reaches breast milk. Researchers measure this with the relative infant dose, which compares the baby's dose through milk with the mother’s dose, adjusted for weight. Across different studies, it was found that breastfed infants receive 0.2% to 2.4% of the mother’s weight-adjusted dose. This low exposure is one reason sertraline is often considered a preferred antidepressant during breastfeeding, although individual circumstances still matter.
Sertraline levels in breast milk can vary over the hours after a dose. For most breastfeeding mothers, timing feeds around medication doses or routinely pumping and discarding milk is not necessary. Ask your prescriber or your baby's pediatrician if your infant was born prematurely or has medical concerns.
Sertraline Levels in Babies' Blood
Most breastfed babies have no measurable sertraline in their blood. A 2015 meta-analysis found that out of the blood samples of 167 infants, 146 (87.4%) samples had sertraline below detectable levels. The authors concluded that routine infant blood testing isn't needed.
Zoloft's FDA labeling reflects similar findings. In a pooled analysis of 53 mother and infant pairs, exclusively breastfed babies had an average sertraline level of about 2% of the parent's blood level, with a range of 0%-15%. No adverse reactions were observed in that sample, although the study was too small to rule out.
How Sertraline Compares to Other SSRIs
A pooled analysis from 2004 of antidepressant levels in nursing infants found that the SSRIs sertraline (Zoloft) and paroxetine (Paxil) and the tricyclic antidepressant nortriptyline usually produced undetectable levels in babies. The SSRIs fluoxetine (Prozac) and citalopram (Celexa) were more likely to show elevated infant levels.
These differences may favor Zoloft during medication selection when starting treatment, but an individual who is stable on another antidepressant does not necessarily need to switch. The decision should account for prior treatment response, the mother’s symptoms, and the baby's health.
What Do Experts Recommend?
Major medical organizations generally support treating depression during breastfeeding. Zoloft is often a first option for someone starting an antidepressant because infant exposure through milk is generally low. However, decisions should be individualized with the prescribing clinician and, when appropriate, the baby's pediatrician.
Here's what several groups recommend:
American College of Obstetricians and Gynecologists (ACOG): Recommends SSRIs as first-line medication for perinatal depression and notes that sertraline and escitalopram (Lexapro) are reasonable first choices for people without a history of medication for depression. It also recommends that people with mental health conditions shouldn't be discouraged from breastfeeding.
Academy of Breastfeeding Medicine (ABM): Describes sertraline as having the best safety profile during lactation and an appropriate first choice for people who haven't taken an antidepressant before. Moreover, antidepressant exposure in breast milk is much lower than that during pregnancy. It also notes that breastfeeding should not delay treatment, as ongoing treatment is critical to both mother’s and baby’s health.
Centers for Disease Control and Prevention (CDC): States that it may be safe to take antidepressant medications while breastfeeding.
Both ACOG and ABM also suggest that if a particular antidepressant worked well for you during pregnancy or in the past, staying on it is often reasonable rather than switching.
Possible Side Effects in Breastfed Babies
Reports of side effects in babies exposed to sertraline through breast milk are uncommon, and most come from single cases or small studies. Reported symptoms in some breastfed infants have included restlessness, sleep changes, irritability, drowsiness, colic, diarrhea, difficulties with temperature regulation leading to either low body temperature or hyperthermia, and feeding difficulties.
Premature Babies and Newborns
Most breastfed infants have no reported adverse effects from sertraline exposure through milk. One small study found infant levels were more likely to be detectable when the mother took higher doses. Other research has found normal weight gain in babies breastfed by mothers taking sertraline.
Rare cases of symptoms resembling neonatal withdrawal have been reported, including in a premature infant whose ability to metabolize sertraline was reduced. A baby's pediatrician may recommend closer monitoring when an infant is premature, very young, or has underlying health conditions.
Temporary newborn adaptation symptoms following SSRI exposure late in pregnancy are a separate issue and are generally attributed to exposure before birth, rather than breastfeeding alone.
Remember, most of the studies conducted were small and many of them reported no adverse effects in breastfed babies. In some of the studies where side effects were reported, other medications in addition to sertraline were also being taken, which could also have had an effect. Routine pediatric checkups, including growth monitoring, are generally considered enough for most babies.
Long-Term Effects on Children
Long-term data are limited but reassuring so far. Small studies following infants up to 5 years have not found adverse developmental effects. A 2025 study involving 97 children found no significant difference in IQ at about age 5 between breastfed children who were and weren't exposed to SSRIs through milk, though the study was small and included several types of SSRIs. Larger studies with longer follow-up are needed.
Can Zoloft Affect Milk Supply?
There's limited research on how sertraline affects milk production, and the FDA prescribing information notes that data specific to sertraline are unavailable.
One observational study found that people taking SSRIs during late pregnancy were more likely to experience delayed onset of copious milk production, but the findings do not establish that sertraline itself causes this delay.
If you notice your supply dropping, consider:
Talking with a lactation consultant about feeding frequency and latch
Feeding or pumping more often in the early weeks
Staying hydrated and eating regularly
Letting your provider know, since depression itself can also affect breastfeeding
The Risks of Untreated Postpartum Depression
When weighing medication, it helps to remember that untreated depression also carries risks. A systematic review of 122 studies found that postpartum depression can affect the parent's health, the bond between parent and baby, breastfeeding, and the child's development.
Treatment decisions should weigh the potential effects of untreated depression against the benefits and possible risks of available treatments. In the United States, mental health conditions, including suicide and overdose, are important contributors to preventable pregnancy-related deaths.
Other Treatment Options for Postpartum Depression
Medication is one option among several. Depending on your symptoms and preferences, your provider may discuss:
Therapy: Cognitive behavioral therapy (CBT) and interpersonal therapy are well-studied for perinatal depression.
Other antidepressants: If another medication worked well for you before, it may be a reasonable choice.
Zuranolone (Zurzuvae): The first oral medication approved specifically for postpartum depression, taken for 14 days. It can cause substantial sedation and impaired driving, so patients should not drive or engage in other hazardous activities until at least 12 hours after each dose. Early research suggests that only a small amount passes into breast milk, but direct data on effects in breastfed infants remain limited.
Support and rest: Help with night feedings, peer support groups, and protected sleep can ease strain alongside treatment.
When to Seek Medical Attention
Contact your provider or your baby's pediatrician if:
Your baby seems unusually sleepy, irritable, or isn't feeding or gaining weight well
Your depression or anxiety isn't improving, or is getting worse
You notice side effects that are hard to manage
You're thinking about stopping or changing your medication
Seek emergency medical help if you experience confusion, hallucinations, delusions, severe disorientation, or thoughts of harming yourself or your baby. These symptoms can indicate a psychiatric emergency, including postpartum psychosis.You can call or text the National Maternal Mental Health Hotline at 1-833-TLC-MAMA (1-833-852-6262), call or text 988 for the Suicide and Crisis Lifeline, or call 911 in an emergency.
How Blossom Health Can Help
Caring for a newborn while coping with postpartum depression can feel overwhelming. Between sleepless nights, feeding schedules, and adjusting to life after birth, finding time to care for yourself may seem difficult. Getting the help you need enables better self-care and equips you to care for your baby.
Blossom Health connects you with licensed, board-certified psychiatrists who can listen to your concerns, monitor your well-being, and work with you to develop a treatment plan that fits your needs. During video visits, your provider can prescribe medication, track your response, and adjust or change your treatment plan when needed. Blossom works with many insurance plans, so check your coverage and book a first appointment, often within days.
Medical Disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice. Always consult a licensed mental health professional to determine which therapy is appropriate for your situation. If you are in crisis, call or text 988.
Sources
National Library of Medicine. (August 15, 2026). Sertraline. Drugs and Lactation Database (LactMed). https://www.ncbi.nlm.nih.gov/books/NBK501191/
U.S. Food and Drug Administration. (2023). Prozac (fluoxetine hydrochloride) capsules and oral solution: Prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019839s108,20990s062lbl.pdf
Sriraman, N. K., Melvin, K., & Meltzer-Brody, S. (2015). ABM Clinical Protocol #18: Use of Antidepressants in Breastfeeding Mothers. Breastfeeding Medicine, 10(6), 290 to 299. https://pmc.ncbi.nlm.nih.gov/articles/PMC4523038/
Weissman, A. M., Levy, B. T., Hartz, A. J., Bentler, S., Donohue, M., Ellingrod, V. L., & Wisner, K. L. (2004). Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. American Journal of Psychiatry, 161(6), 1066 to 1078. https://pubmed.ncbi.nlm.nih.gov/15169695/
Hendrick, V., Fukuchi, A., Altshuler, L., Widawski, M., Wertheimer, A., & Brunhuber, M. V. (2001). Use of sertraline, paroxetine and fluvoxamine by nursing women. British Journal of Psychiatry, 179(2), 163 to 166. https://pubmed.ncbi.nlm.nih.gov/11483479/
Pinheiro, E., Bogen, D. L., Hoxha, D., Ciolino, J. D., & Wisner, K. L. (2015). Sertraline and breastfeeding: review and meta-analysis. Archives of Women's Mental Health, 18(2), 139 to 146. https://pubmed.ncbi.nlm.nih.gov/25589155/
Heinonen, E. W., Kao, K., Mattson, S. N., & Chambers, C. D. (2025). Cognitive Outcomes of Children Exposed to Selective Serotonin Reuptake Inhibitors Through Breast Milk. JAMA Network Open, 8(11), e2544989. https://pmc.ncbi.nlm.nih.gov/articles/PMC12639480/
Marshall, A. M., Nommsen-Rivers, L. A., Hernandez, L. L., Dewey, K. G., Chantry, C. J., Gregerson, K. A., & Horseman, N. D. (2010). Serotonin transport and metabolism in the mammary gland modulates secretory activation and involution. Journal of Clinical Endocrinology and Metabolism, 95(2), 837 to 846. https://pubmed.ncbi.nlm.nih.gov/19965920/
ACOG Committee on Clinical Practice Guidelines, Obstetrics. (2023). Treatment and Management of Mental Health Conditions During Pregnancy and Postpartum: ACOG Clinical Practice Guideline No. 5. Obstetrics and Gynecology, 141(6), 1262 to 1288. https://pubmed.ncbi.nlm.nih.gov/37486661/
Bauman, B. L., Ko, J. Y., Cox, S., et al. (May 15, 2020). Vital Signs: Postpartum Depressive Symptoms and Provider Discussions About Perinatal Depression, United States, 2018. Morbidity and Mortality Weekly Report, 69(19), 575 to 581. Centers for Disease Control and Prevention. https://www.cdc.gov/mmwr/volumes/69/wr/mm6919a2.htm
Slomian, J., Honvo, G., Emonts, P., Reginster, J. Y., & Bruyère, O. (2019). Consequences of maternal postpartum depression: A systematic review of maternal and infant outcomes. Women's Health, 15, 1745506519844044. https://pmc.ncbi.nlm.nih.gov/articles/PMC6492376/
National Institute of Mental Health. (2023). Perinatal Depression (NIH Publication No. 23-MH-8116). https://www.nimh.nih.gov/health/publications/perinatal-depression
Centers for Disease Control and Prevention. (September 23, 2025). Postpartum Depression: Breastfeeding Special Circumstances. https://www.cdc.gov/breastfeeding-special-circumstances/hcp/illnesses-conditions/postpartum-depression.html
Cleveland Clinic. (March 26, 2026). Postpartum Depression (PPD): Causes, Symptoms and Treatment. https://my.clevelandclinic.org/health/diseases/9312-postpartum-depression
U.S. Food and Drug Administration. (August 04, 2023). FDA Approves First Oral Treatment for Postpartum Depression. https://www.fda.gov/news-events/press-announcements/fda-approves-first-oral-treatment-postpartum-depression
